EUVIMEDEUVIMED entdecken
Crossref

Withdrawal syndrome, discontinuation syndrome and rebound effect in the treatment with selected drug classes

Barbara Sobera, Mateusz Gadzała, Przemysław Mikołajczak, Dagmara Mirowska-Guzel

Pharmacotherapy in Psychiatry and Neurology · 2025 · 41 (2) · 141-155

DOI: 10.5114/fpn.2025.159504 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacotherapy in Psychiatry and Neurology, 2025. Verfasst von Barbara Sobera und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sobera, B., Gadzała, M., Mikołajczak, P., & Mirowska-Guzel, D. (2025). Withdrawal syndrome, discontinuation syndrome and rebound effect in the treatment with selected drug classes. Pharmacotherapy in Psychiatry and Neurology, 41(2), 141-155. https://doi.org/10.5114/fpn.2025.159504

Vancouver

Sobera B, Gadzała M, Mikołajczak P, Mirowska-Guzel D. Withdrawal syndrome, discontinuation syndrome and rebound effect in the treatment with selected drug classes. Pharmacotherapy in Psychiatry and Neurology. 2025;41(2):141-155. doi:10.5114/fpn.2025.159504

BibTeX
@article{Sobera2025,
  author = {Sobera, Barbara and Gadzała, Mateusz and Mikołajczak, Przemysław and Mirowska-Guzel, Dagmara},
  title = {Withdrawal syndrome, discontinuation syndrome and rebound effect in the treatment with selected drug classes},
  journal = {Pharmacotherapy in Psychiatry and Neurology},
  year = {2025},
  volume = {41},
  number = {2},
  pages = {141--155},
  doi = {10.5114/fpn.2025.159504}
}
Kostenlos starten →